InvestorsHub Logo
Followers 21
Posts 980
Boards Moderated 0
Alias Born 03/20/2019

Re: Biobillionair post# 292313

Saturday, 08/22/2020 6:04:38 PM

Saturday, August 22, 2020 6:04:38 PM

Post# of 426501
Right now we've got a standoff. If generics (Hikma) are at 2025 and AMRN is at 2029 (TEVA deal) both sides should presumably move off that on the eve of trial (Sept. 1st). The big reveal will be the panel on Sept. 2nd.

Do both sides really want to go trial? Is it in the best interest of both sides. One side will come out of Sept. 2nd feeling a lot better based on the panel and the questions.

Smarter heads should split the difference with a 2027 early entry or early 2028 and avoid trial.

Time will tell. Can only bluff and hold court for so long. Sept. 2nd is coming.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News